Gastrointestinal Cancer News

A woman with metastatic pancreatic cancer attained a 72% partial response with T-cell receptor gene therapy, according to a report published in The New England Journal of Medicine.

The percentage of patients presenting with late-stage breast and colorectal cancers increased between 2019 and 2020 at Moores Cancer Center at University of California San Diego Health, according to data published in JAMA Network Open.

Women demonstrated a 34% increased risk for severe adverse events from any cancer treatment compared with men, according to a study published in Journal of Clinical Oncology.

The FDA approved nivolumab plus fluoropyrimidine- and platinum-containing chemotherapy and nivolumab plus ipilimumab as first-line treatments for adults with unresectable advanced or metastatic esophageal squamous cell carcinoma.

High alcohol consumption was significantly associated with an increased risk for colorectal cancer, regardless of genetic risk, according to findings published in The Lancet’s eClinical Medicine.

As telemedicine use increased during the COVID-19 pandemic, Black patients with cancer had lower usage levels than white patients, according to study results presented during a virtual press briefing ahead of the ASCO Annual Meeting.

Increased state spending on social services such as Medicaid correlated with improved 5-year overall survival among Black adults with cancer, according to study results scheduled for presentation at ASCO Annual Meeting.

Greater adult-attained height correlated with increased risk for colorectal cancer and adenoma, according to a meta-analysis published in Cancer, Epidemiology, Biomarkers & Prevention.

SAN DIEGO — Pre-alert text message notification followed by mailed fecal immunochemical test kits improved population-level screening for colorectal cancer during COVID-19, according to research.

ASCO and the Association of Community Cancer Centers have jointly developed recommendations for improving equity, diversity and inclusion in cancer clinical trials.